Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Andrew H. Rodgers"'
Publikováno v:
Anticancer Research. 43:1407-1413
Autor:
Lee Roy Morgan, Roy S. Weiner, Tallat Mahmood, Marcus L. Ware, Andrew H. Rodgers, Manish Bhandari, Philip Friendlander
Publikováno v:
Molecular Cancer Therapeutics. 20:P038-P038
Background: 4-Demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) is a poly-chlorinated pyridine cholesteryl carbonate with a MOA via bis-alkylation of DNA @ N7-guanine and N4-cytosine that is currently in Phase II trial in AYA subjects with
Autor:
Andrew H. Rodgers, M. Bhandari, Philip Friedlander, Tallat Mahmood, Marcus L. Ware, Lee Roy Morgan, Roy S. Weiner
Publikováno v:
Cancer Research. 80:CT181-CT181
Background: 4-Demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) is a poly-chlorinated pyridine cholesteryl carbonate with a MOA via bis-alkylation of DNA @ N7-guanine and N4-cytosine that has completed Phase I and now in Phase II clinical t
Publikováno v:
Molecular Cancer Therapeutics. 18:A098-A098
Background: 4-Demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) is a poly-chlorinated pyridine cholesteryl carbonate with a MOA via bis-alkylation of DNA @ N7-guanine and N4-cytosine. DM-CHOC-PEN has completed Phase I/II studies as a single
Autor:
Marc R. Matrana, Marcus L. Ware, Thomas Cosgriff, Jay J. Zou, Philip Friedlander, Craig Gordon, M. Bhandari, Andrew H. Rodgers, Lee Roy Morgan, Tallat Mahmood, Roy S. Weiner
Publikováno v:
Cancer Research. 81:CT152-CT152
Background: 4-Demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) is a poly-chlorinated pyridine cholesteryl carbonate with a MOA via bis-alkylation of DNA @ N7-guanine and N4-cytosine that has completed Phase I and II trials (the latter incl
Autor:
M. Bhandari, Roy S. Weiner, Marcus L. Ware, Andrew H. Rodgers, Tallat Mahmood, Philip Friedlander, Lee Roy Morgan
Publikováno v:
Molecular Cancer Therapeutics. 17:A086-A086
Background: 4-Demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) is a poly-chlorinated pyridine cholesteryl carbonate with a MOA via bis-alkylation of DNA @ N7-guanine and N4-cytosine that has completed phase I and II trials in adult subject
Autor:
Lee Roy Morgan, Andrew H. Rodgers
Publikováno v:
New Approaches to the Management of Primary and Secondary CNS Tumors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::846867e65ae78041be92c3fc311b6760
http://www.intechopen.com/articles/show/title/neuropharmacology-as-applied-to-designing-new-chemotherapeutic-agents
http://www.intechopen.com/articles/show/title/neuropharmacology-as-applied-to-designing-new-chemotherapeutic-agents
Autor:
Philip Friedlander, M. Bhandari, Andrew H. Rodgers, Lee Roy Morgan, James Herman, K Devisitty, Marcus L. Ware, Roy S. Weiner, R. Kawauchi, Tallat Mahmood, R Summe
Publikováno v:
Cancer Research. 78:CT119-CT119
Purpose:4-Demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) is a poly-chlorinated pyridine cholesteryl carbonate with a mechanism of action (MOA) via bis-alkylation of DNA @ N7-guanine and N4-cytosine that has completed Phase I/II studies [